Literature DB >> 20667057

Functional impairment and disability across mood states in bipolar disorder.

Adriane R Rosa1, María Reinares, Erin E Michalak, C Mar Bonnin, Brisa Sole, Carolina Franco, Mercè Comes, Carla Torrent, Flávio Kapczinski, Eduard Vieta.   

Abstract

BACKGROUND: Bipolar disorder (BD) represents a chronic and recurrent illness that can lead to severe disruptions in family, social, and occupational functioning. The severity of mood symptomatology has been associated with functional impairment in this population. However, the majority of studies have assessed global functioning without considering specific domains. The main objective of the current study was to assess specific life domains of functioning as well as the overall functioning in patients with BD across different mood states ([hypo] mania, depression, or euthymia) compared with healthy controls by the means of a standardized scale validated for BD.
METHODS: The sample included 131 subjects with BD (68 in remission, 31 hypo [manic], and 32 depressed) and 61 healthy controls. The Functioning Assessment Short Test was used to assess overall and multiple areas of functional impairment (autonomy, occupational functioning, cognitive functioning, interpersonal relationships, financial issues, and leisure time).
RESULTS: The results showed significant intergroup differences; depressed patients had the lowest functioning (48.03 ± 12.38) followed by (hypo) manic patients (39.81 ± 13.99). The euthymic group showed least impairment in functioning compared with the depression and (hypo) mania groups (11.76 ± 12.73) but still displayed significant impairment when compared with the healthy control group (5.93 ± 4.43).
CONCLUSIONS: This study indicates that depressive symptoms are associated with greater negative impact on psychosocial functioning than (hypo) manic symptoms. Further deficits in functioning seem to persist during remission. The results highlight the importance of aggressively treating depression and mania and the need to develop psychosocial interventions targeting to improve functional outcomes.
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Entities:  

Mesh:

Year:  2010        PMID: 20667057     DOI: 10.1111/j.1524-4733.2010.00768.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  53 in total

1.  Correlates of real world executive dysfunction in bipolar I disorder.

Authors:  Amy T Peters; Andrew D Peckham; Jonathan P Stange; Louisa G Sylvia; Natasha S Hansen; Stephanie Salcedo; Scott L Rauch; Andrew A Nierenberg; Darin D Dougherty; Thilo Deckersbach
Journal:  J Psychiatr Res       Date:  2014-03-02       Impact factor: 4.791

2.  The role of lifetime anxiety history in the course of bipolar spectrum disorders.

Authors:  Madison K Titone; Rachel D Freed; Jared K O'Garro-Moore; Andrew Gepty; Tommy H Ng; Jonathan P Stange; Lyn Y Abramson; Lauren B Alloy
Journal:  Psychiatry Res       Date:  2018-04-03       Impact factor: 3.222

3.  Behavioral approach system sensitivity and risk taking interact to predict left-frontal EEG asymmetry.

Authors:  Chelsea L Black; Kim E Goldstein; Denise R LaBelle; Christopher W Brown; Eddie Harmon-Jones; Lyn Y Abramson; Lauren B Alloy
Journal:  Behav Ther       Date:  2014-01-30

Review 4.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 5.  Bipolar depression: an evidence-based approach.

Authors:  Claudia F Baldassano; Alexander Hosey; Jordan Coello
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

6.  Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Carlos Blanco; Wilson M Compton; Tulshi D Saha; Benjamin I Goldstein; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Psychiatr Res       Date:  2016-10-07       Impact factor: 4.791

Review 7.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

Review 8.  Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.

Authors:  Eduard Vieta; Marc Valentí
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

9.  Differential hedonic experience and behavioral activation in schizophrenia and bipolar disorder.

Authors:  Ivy F Tso; Tyler B Grove; Stephan F Taylor
Journal:  Psychiatry Res       Date:  2014-06-25       Impact factor: 3.222

10.  Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.

Authors:  Erik Johnsen; Rune A Kroken
Journal:  Ther Adv Chronic Dis       Date:  2012-11       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.